Earl A. Surwit

4.5k total citations
89 papers, 3.4k citations indexed

About

Earl A. Surwit is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Earl A. Surwit has authored 89 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Reproductive Medicine, 29 papers in Surgery and 23 papers in Obstetrics and Gynecology. Recurrent topics in Earl A. Surwit's work include Ovarian cancer diagnosis and treatment (35 papers), Endometrial and Cervical Cancer Treatments (23 papers) and Cervical Cancer and HPV Research (11 papers). Earl A. Surwit is often cited by papers focused on Ovarian cancer diagnosis and treatment (35 papers), Endometrial and Cervical Cancer Treatments (23 papers) and Cervical Cancer and HPV Research (11 papers). Earl A. Surwit collaborates with scholars based in United States, Canada and Myanmar. Earl A. Surwit's co-authors include Joel M. Childers, Kenneth D. Hatch, David S. Alberts, John R. Davis, J M Childers, Edward V. Hannigan, Alton V. Hallum, Thomas E. Moon, David S. Grosso and Charles B. Hammond and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and JNCI Journal of the National Cancer Institute.

In The Last Decade

Earl A. Surwit

87 papers receiving 3.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Earl A. Surwit 1.4k 1.3k 1.2k 566 479 89 3.4k
Alberto Manetta 1.3k 0.9× 1.3k 1.0× 841 0.7× 561 1.0× 531 1.1× 116 3.0k
Gunter Deppe 941 0.7× 966 0.7× 845 0.7× 622 1.1× 303 0.6× 137 2.5k
Elvis S. Donaldson 949 0.7× 1.4k 1.1× 573 0.5× 459 0.8× 337 0.7× 98 2.8k
Edward V. Hannigan 1.9k 1.4× 2.0k 1.5× 1.9k 1.6× 875 1.5× 426 0.9× 80 4.3k
Joseph Menczer 1.6k 1.2× 857 0.6× 533 0.4× 612 1.1× 435 0.9× 167 2.9k
Paul R. Kucera 2.3k 1.6× 857 0.6× 1.4k 1.1× 1.1k 1.9× 573 1.2× 32 3.3k
Stefania Cosio 1.7k 1.3× 1.5k 1.1× 757 0.6× 893 1.6× 729 1.5× 118 3.4k
J. S. Berek 1.2k 0.8× 1.1k 0.8× 1.3k 1.1× 518 0.9× 334 0.7× 48 2.7k
G. Favalli 1.9k 1.3× 1.0k 0.8× 1.3k 1.1× 606 1.1× 293 0.6× 45 2.7k
Toru Nakanishi 1.5k 1.1× 1.6k 1.2× 930 0.8× 682 1.2× 1.1k 2.2× 148 4.3k

Countries citing papers authored by Earl A. Surwit

Since Specialization
Citations

This map shows the geographic impact of Earl A. Surwit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Earl A. Surwit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Earl A. Surwit more than expected).

Fields of papers citing papers by Earl A. Surwit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Earl A. Surwit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Earl A. Surwit. The network helps show where Earl A. Surwit may publish in the future.

Co-authorship network of co-authors of Earl A. Surwit

This figure shows the co-authorship network connecting the top 25 collaborators of Earl A. Surwit. A scholar is included among the top collaborators of Earl A. Surwit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Earl A. Surwit. Earl A. Surwit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Surwit, Earl A., et al.. (2008). Postoperative Care. The Global Library of Women s Medicine.
3.
Surwit, Earl A. & J M Childers. (1998). Role of operative laparoscopy in gynecologic oncology. Cancer treatment and research. 95. 235–251.
4.
Surwit, Earl A., et al.. (1995). Laparoscopic hysterectomy for persistent gestational trophoblastic neoplasia. The Journal of the American Association of Gynecologic Laparoscopists. 2(4). 475–477. 7 indexed citations
5.
Childers, Joel M., et al.. (1995). Laparoscopic Surgical Staging of Ovarian Cancer. Gynecologic Oncology. 59(1). 25–33. 113 indexed citations
6.
Malviya, Vinay K., P. Y. Liu, Robert V. O’Toole, et al.. (1994). Phase II Trial of Amonafide in Patients with Advanced Metastatic or Recurrent Endometrial Adenocarcinoma A Southwest Oncology Group Study. American Journal of Clinical Oncology. 17(1). 37–40. 9 indexed citations
7.
Alberts, D S, Edward V. Hannigan, Renzo Canetta, et al.. (1994). Cisplatin versus carboplatin in advanced ovarian cancer: An economic analysis. 19(7). 3 indexed citations
8.
Childers, Joel M., et al.. (1994). Laparoscopic Staging of the Patient With Incompletely Staged Early Adenocarcinoma of the Endometrium. Obstetrics and Gynecology. 83(4). 597–600. 59 indexed citations
9.
Meyskens, F. L., Earl A. Surwit, Thomas E. Moon, et al.. (1994). Enhancement of Regression of Cervical Intraepithelial Neoplasia II (Moderate Dysplasia) With Topically Applied All- trans -Retinoic Acid: a Randomized Trial. JNCI Journal of the National Cancer Institute. 86(7). 539–543. 199 indexed citations
10.
Surwit, Earl A., Joel M. Childers, David N. Krag, et al.. (1993). Clinical Assessment of 111In-CYT-103 Immunoscintigraphy in Ovarian Cancer. Gynecologic Oncology. 48(3). 285–292. 38 indexed citations
11.
Hannigan, Edward V., Stephanie Green, David S. Alberts, Robert V. O’Toole, & Earl A. Surwit. (1993). Results of a Southwest Oncology Group Phase III Trial of Carboplatin plus Cyclophosphamide versus Cisplatin plus Cyclophosphamide in Advanced Ovarian Cancer. Oncology. 50(2). 2–9. 26 indexed citations
12.
Childers, Joel M. & Earl A. Surwit. (1992). Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer. Gynecologic Oncology. 45(1). 46–51. 138 indexed citations
13.
Malviya, Vinay K., P. Y. Liu, David S. Alberts, et al.. (1992). Evaluation of Amonafide in Cervical Cancer, Phase II. American Journal of Clinical Oncology. 15(1). 41–44. 53 indexed citations
14.
Childers, Joel M., Kenneth D. Hatch, & Earl A. Surwit. (1992). The role of laparoscopic lymphadenectomy in the management of cervical carcinoma. Gynecologic Oncology. 47(1). 38–43. 135 indexed citations
15.
Plezia, Patricia M., D S Alberts, Min Xu, et al.. (1989). The role of serum and tissue pharmacology studies in the design and interpretation of chemoprevention trials. Preventive Medicine. 18(5). 680–687. 4 indexed citations
16.
Alberts, David S., Robert V. O’Toole, Thomas M. Abbott, et al.. (1989). Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: A Southwest Oncology Group study. Gynecologic Oncology. 32(1). 16–21. 8 indexed citations
17.
Alberts, David S., Robert V. O’Toole, Thomas M. Abbott, et al.. (1989). Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: A Southwest Oncology Group study. Gynecologic Oncology. 32(1). 8–15. 15 indexed citations
18.
Weiner, Sheldon, et al.. (1988). A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. Gynecologic Oncology. 30(1). 1–6. 41 indexed citations
19.
Alberts, David S., S. E. Salmon, & Earl A. Surwit. (1981). Combination chemotherapy (CRx) in vitro with the human tumor stem cell assay (HTSCA). Proceedings of the American Association for Cancer Research. 22. 3 indexed citations
20.
Surwit, Earl A., et al.. (1978). Stage II carcinoma of the endometrium. An analysis of treatment.. PubMed. 52(1). 97–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026